Share chart Global Blood Therapeutics, Inc.
Extended chart
Simple chart
About Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc., биофармацевтическая компания, работающая на клинической стадии, занимается открытием, разработкой и предоставлением методов лечения для недостаточно обслуживаемых сообществ пациентов. Он разрабатывает свой главный кандидат на продукт, таблетки Oxbryta (вокселотор), пероральный препарат для лечения серповидно-клеточной анемии (SCD), принимаемый один раз в день. Компания оценивает Oxbryta, которая завершила клинические испытания фазы III у взрослых и подростков с SCD. more detailsIPO date | 2015-08-12 |
---|---|
ISIN | US37890U1088 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | http://www.gbt.com |
Цена ао | 67.5 |
Change price per day: | 0% (68.49) |
---|---|
Change price per week: | 0% (68.49) |
Change price per month: | 0% (68.49) |
Change price per 3 month: | 0% (68.49) |
Change price per half year: | 0% (68.49) |
Change price per year: | 0% (68.49) |
Change price per 3 year: | +166.71% (25.68) |
Change price per 5 year: | +26.41% (54.18) |
Change price per year to date: | 0% (68.49) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Transaction date | Date of disclosure | Insider | Type | Price | Volume | Quantity | Share before, % | Share after, % | Document |
---|---|---|---|---|---|---|---|---|---|
27.09.2022 | 29.09.2022 | Choi Jung See Remarks |
Purchase | 7.04 | 700 403 | 99489 | 0 | 0.15 | link |
27.09.2022 | 29.09.2022 | LOVE TED W President and CEO |
Purchase | 16.4 | 299 972 | 18291 | 0 | 0.03 | link |
27.09.2022 | 29.09.2022 | Habibizad Nazila See Remarks |
Purchase | 19.17 | 570 403 | 29755 | 0 | 0.05 | link |
27.09.2022 | 29.09.2022 | Farrow Jeffrey S Chief Financial Officer |
Purchase | 16.4 | 387 909 | 23653 | 0 | 0.04 | link |
01.09.2022 | 06.09.2022 | Farrow Jeffrey S Chief Financial Officer |
Sale | 68 | 2 137 990 | 31441 | 0 | -0.05 | link |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Jeffrey S. Farrow | CFO & Principal Accounting Officer | 672.67k | 1962 (63 years) |
Ms. Jung E. Choi | Chief Bus. & Strategy Officer | 645k | 1970 (55 years) |
Mr. David L. Johnson | Chief Commercial Officer | 661.5k | 1969 (56 years) |
Dr. David R. Phillips | Founder & Advisor | N/A | |
Ms. Nazila Habibizad | Exec. VP of Operations | N/A | 1963 (62 years) |
Stephanie Yao | Sr. Director of Corp. Communications & Investor Relations | N/A | |
Dr. Matthew P. Jacobson Ph.D. | Founder & Advisor | N/A | |
Dr. Andrej Sali Ph.D. | Founder & Advisor | N/A | |
Dr. Ted W. Love M.D. | Pres, CEO & Director | 1.06M | 1959 (66 years) |
Dr. Kim Smith-Whitley M.D. | Exec. VP and Head of R&D | 654k | 1961 (64 years) |
Address: United States, South San Francisco, 181 Oyster Point Boulevard - open in Google maps, open in Yandex maps
Website: http://www.gbt.com
Website: http://www.gbt.com